P2-020: Targeting preclinical stages of Alzheimer’s disease: A clinical trial to assess the efficacy of curcumin using brain biomarkers
Tools
Tools
Tools
Goozee, K.G., Chatterjee, P., Sohrabi, H.R.
ORCID: 0000-0001-8017-8682, Shen, K.K., Ball, B., Dave, P., ManYan, C., Asih, P.R., Taddei, K. and Martins, R.N.
(2016)
P2-020: Targeting preclinical stages of Alzheimer’s disease: A clinical trial to assess the efficacy of curcumin using brain biomarkers.
Alzheimer's & Dementia, 12
(7S Pt.12).
P616-P616.
Link to Published Version: https://doi.org/10.1016/j.jalz.2016.06.1224
*Subscription may be required
*Subscription may be required
Abstract
Poster presentation
| Item Type: | Journal Article |
|---|---|
| Publisher: | Wiley |
| Copyright: | © 2016 The Alzheimer's Association |
| URI: | http://researchrepository.murdoch.edu.au/id/eprint/55930 |
 |
Item Control Page |